ARTICLE | Company News
Meridian Bioscience sales and marketing update
August 15, 2011 7:00 AM UTC
Meridian launched its ImmunoCard C. difficile test in Europe to detect Clostridium difficile infection (CDI). The assay detects glutamate dehydrogenase in stool samples. ...